The direct introduction with micropipettes of poly(rI), poly(rC) into the cytoplasm of several human cell lines inhibited the multiplication of vesicular stomatitis virus. This antiviral activity was at least partly due to interferon (IFN) production and secretion from the injected cells since it was species-specific, partly neutralized by iFN antibodies and was transmissible to non-adjacent cells. This suggests a mechanism of IFN induction involving the internalization of poly(rI)-poly(rC) and its interaction with an intracellular target.
INTRODUCTION
The discovery of the potent interferon (IFN)-inducing capacity of double-stranded RNAs (dsRNAs) and of poly(rI).poty(rC) in particular nearly 20 years ago (Lampson et al., 1967) has rapidly led to a profusion of information, reviewed comprehensively by Torrence & De Clercq (1977) and by Pitha & Hutchinson (1977) . Purification of the IFNs and successful cloning of their genes have been achieved recently and DNA sequences governing the inducibility of IFN genes by viruses or by poly(rI), poly(rC) have started to be elucidated (for review, see Collins, 1984) . Very little is known about the early phases of IFN induction by dsRNAs, and most of the basic questions repeatedly raised over the last 20 years still remain unsolved (Burke, 1977; Vil&k, 1984) . Several studies [initiated by Bausek & Merigan (1969) and reviewed by Pitha & Hutchinson (l 977) ] concerning the timing and the specificity of the binding of poly(rI), poly(rC) to the cell surface have led to the conclusion that a short exposure of the cells to dsRNA is sufficient to induce IFN synthesis. Whether this primary interaction of poly(rI), poly(rC) with a putative receptor at the cell membrane rapidly generates a second messenger-like signal or whether internalization of the inducer itself takes place is still a matter of debate. Mechanisms for the uptake of polynucleotides by animal cells exist (for review, see Stebbing, 1979) . It has been shown for instance that purified viral RNAs are infectious (Pagano, 1970) . Autoradiographic studies have revealed that synthetic double-stranded RNAs like poly(rI)-poly(rC) are rapidly taken up by cultured cells (Pitha & Hutchinson, 1977) .
On the other hand, the IFN-inducing capacity of poly(rI), poly(rC) is enhanced by treatment of cells with a number of polycationic substances. This is true both in vitro (for review, see Stebbing, 1979) and in vivo (for review, see Levy, 1980) . It is not clear, however, to what extent the observed stimulation is really due to an increased uptake of the polynucleotides. The observed effect may also be attributable to a better protection of the poly(rI).poly(rC) against serum nucleases (Fuller & Marcus, 1979) . Alterations of the plasma membranes by complexed polycations may have to be considered as well, as discussed by Pitha & Hutchinson (1977) . Treatment of cells with poly(rI), poly(rC) encapsulated in various types of liposomes increases IFN production both in culture (Mayhew et al., 1977) and in mice (Straub et al., 1974) . It is assumed that liposome inclusion results in a better cellular uptake but here again protection of poly(rI).poly(rC) against nucleolytic degradation could explain the results. This and other pitfalls of liposome technology do not allow unambiguous distinction between cell membrane and intracellular interaction sites for poly(rI).poly(rC).
Much effort has been directed towards studies of the ]FN induction capacity of polynucleotide inducers adsorbed or covalently linked to various supports supposed to prevent internalization (e.g. activated Sepharose, sheets of cellophane or red blood cells). This aspect has been extensively reviewed and discussed by Pitha & Hutchinson (1977) . Antiviral activity has been induced in cells placed in contact with those matrix-bound polynucleotides in most cases, suggesting that the interaction of poly(rI), poly(rC) with the cell surface is all that is required for IFN induction. However, possible release of poly(rI), poly(rC) from the support does not allow one to establish conclusively whether synthetic double-stranded RNA inducers need to enter the cell in order to induce IFN production.
We establish here that the direct microinjection of tiny amounts of poly(rI).poly(rC) with micropipettes into the cytoplasm induces an antiviral response due at least in part to IFN induction.
METHODS

Materials.
Human recombinant IFNs, HulFN-fl at a specific activity of 5 x 107 international units/mg protein and HulFN-ct 2 at a specific activity of > 1.3 x 108 international units/mg protein, were obtained from W. Fiers and L. Gauci, respectively. HulFN-ct and HulFN-fl antisera were obtained from J. Van Damme and E. Meurs, respectively. Poly(rI). poly(rC) was purchased from P-L Biochemicals, bovine pancreatic RNase A (EC 3.1.27.5) from Sigma and actinomycin D from Merck, Sharp and Dohme.
Cell culture. HeLa cells were grown in monolayers in RPMI 1640 medium (Eurobio) supplemented with 10~ (v/v) foetal calf serum (Flow Laboratories), 50 units/ml penicillin and 50 ~tg/ml streptomycin. For microinjection experiments, HeLa cells were grown on small pieces of glass coverslips of approx. 2 mm z. Two-hundred to 400 cells were plated on each glass fragment (Huez et al., 1981) .
L929 cells were grown in monolayer culture in minimal essential medium (Eurobio) supplemented with 3 g/l Bacto tryptose phosphate, 3.4 g/1 glucose, 10~ (v/v) foetal calf serum and antibiotics as above. MG63, Chinese hamster ovary (CHO) and WISH cells were grown in monolayers in DMEM supplemented with 10% (v/v) foetal calf serum, and antibiotics as above.
Microinjection. Microinjections were performed according to the method originally described by Graessmann et al. (1980) . The coverslips carrying cells to be injected were placed in Petri dishes containing 7 ml serum-free culture medium. Samples of 0.1 to 0.5 nl, which represents approximately 1 to 5~ of the cell volume, were introduced in the cytoplasm of each cell with glass micropipettes of 0.5 to 1 ~tm diameter at the tip. Injection of the cells was performed over a period of approximately 30 min at room temperature. The sample was forced into the cell under low N2 pressure as described by Ansorge (1982) and injections were monitored under a phase-contrast Wild-Leitz Diavert microscope at a magnification of x 320. The coverslips were then rinsed carefully three or four times in 7 ml serum-free culture medium before further incubation in 100 to 200 ~110~ (v/v) serum-supplemented growth medium at 37 °C in microtitration plates.
Assay ofantiviral activity. Cells were infected at the times indicated, usually 18 h after the microinjection of poly(rI), poly(rC), with vesicular stomatitis virus (VSV, Indiana serotype) at a multiplicity of 10 for 1 h at 37 °C in RPMI 1640 medium supplemented with 5 ~ (v/v) foetal calf serum. Unadsorbed viruses were removed by three washings with RPMI. Virus yield was determined 20 to 24 h later according to published procedures (Stewart & Lockart, 1970) . Briefly, 106 L929 cells were plated on tissue culture Petri dishes (2 cm diam.). After 24 h of incubation the medium was discarded and 0.05 ml of the diluted virus suspension (dilution factor 50) was carefully spread over the cell monolayer. One h later the virus suspension was removed by suction and 2 ml 1-6~ (v/v) melted agarose in minimal essential medium supplemented with 2 % (v/v) foetal calf serum was overlaid on the cell monolayer. The plates were incubated for about 18 h in a CO2 incubator. The plaques were revealed with a 1 (v/v) solution of neutral red in isotonic phosphate-buffered saline.
RESULTS
Antiviral activity of microinjected poly(rI).poly(rCO in cultured cells
In order to establish whether the triggering of IFN induction by synthetic double-stranded polyribonucleotides is initiated from the cell surface or from an intracellular site, poly(rI)-poly(rC) was microinjected into different cell lines. Since these experiments involved only a limited number of cells (100 to 400), direct quantification of IFN production was not possible. The effect of poly(rI)-poly(rC) injection on IFN induction was thus estimated * Cells were each microinjected with 0.5 nl H20 or with 0-5 nl poly(rI), poly(rC) (100 ~tg/ml) in sterile aqueous solution. Since 0.5 nl represents approximately one-tenth of the cell volume, it can be assumed that the final intracytoplasmic concentration of poly(rI), poly(rC) was around 10 ~tg/ml. Microinjected cells were challenged 18 h later with VSV (m.o.i. 10) and virus yields were determined 20 h later by plaque assay on L929 cells. Poly(rI).poly(rC) after KOH hydrolysis 6-2 x l0 s No KOH hydrolysis < 10 * Cells were each microinjected with 0-5 nl H20 (no treatment) or 0-5 nl poly(rI)-poly(rC) at the indicated concentration (p,g/ml) in expt. 1. In expt. 2, cells were microinjected with 10 ~tg/ml poly(rI).poly(rC) with or without RNase A (10 ~tg/ml) in the culture medium in order to neutralize any leakage of poly(rI)-poly(rC) from the microinjection needle or from the injected cell. In expt. 3, a 1.0 mg/ml aqueous solution of poly(rI), poly(rC) was incubated for 18 h with 1 M-KOH and neutralized with HC1 before injection; the control was treated in the same conditions except for the omission of the incubation with KOH. The cells were challenged with VSV and virus yields were determined as described in Table 1. indirectly by monitoring the replication of VSV. This approach was based on earlier work stressing the major role played by IFN induction as the basis for the development of an antiviral activity in poly(rI), poly(rC)-treated cultured cells (Vengris et al., 1975 ; for review, see Torrence & De Clercq, 1977) . As shown in Table 1 , the microinjection of poly(rI).poly(rC) into several human cell lines triggered the development of an antiviral activity as measured by challenging the injected cells 18 h later with VSV. Although the use of different cell lines established the generality of the observation, most experiments described below were performed with HeLa cells since they exhibited attachment properties and mechanical resistance ideal for micro-manipulation. In all cell lines considered here poly(rI), poly(rC) was still active at inhibiting VSV growth when the concentration of the injected solution was adjusted to 1 ~tg/ml (Table 2) . This corresponded to a final intracellular concentration of 10 ng/ml or less. The threshold value for antiviral activity of microinjected poly(rI), poly(rC) in HeLa cells varied from experiment to experiment and was as low as 10 ng/ml in some experiments as shown in Table 2 .
Cell leakage could not be avoided either during the microinjection process or during subsequent incubation of the injected cells. It seemed however highly improbable that the observed results were due to this phenomenon. Indeed, HeLa cells in particular were barely sensitive to poly(rI).poly(rC) even at concentrations as high as 10 ~tg/ml in the incubation medium (data not shown). In addition, material leaking from the micropipette or from the injected cell would have been extensively diluted in our experimental conditions (see Methods). Finally, similar data were obtained with poly(rI), poly(rC)-injected HeLa cells incubated in the presence of 10 ~tg/ml RNase A, i.e. in conditions allowing the complete inactivation of external poly(rI).poly(rC) ( Table 2 ). In contrast, poly(rI).poly(rC) hydrolysed by alkaline treatment prior to injection did not reduce VSV yield when microinjected into HeLa cells (Table 2) . 3.4 × 103 + IFN-~tfl Ab * HeLa cells were each microinjected with 0.5 nl of a 1 gg/ml sterile aqueous solution of poly(rI)-poly(rC) and incubated with or without a mixture of antisera neutralizing HulFN-ct and HulFN-fl (103 units; IFN-ctfl Ab) as indicated. Control uninjected cells were incubated with or without a mixture of HulFN-ct2 and HulFN-fl (500 units of each; IFN ctfl) and IFN-ctfl Ab as mentioned. Cells were challenged with VSV 18 h later and virus yields were determined as described in Table 1 .
Antiviral activity of microinjected poly(rl).poly(rC) is neutralized part&lly by IFN antisera
It is well established that cells induced to produce IFN with exogenous poly(rI), poly(rC) do not become protected against virus infection if incubated in the presence of the appropriate IFN antibodies, which implies that IFN has to be externalized to develop a biological effect even in producing cells (Vengris et al., 1975) . In order to test whether the antiviral protection observed in our experimental scheme was indeed due to IFN production and secretion, poly(rI), poly(rC) was injected into HeLa cells incubated in the presence of human IFN antisera. The antibodies were present throughout the entire experiment at concentrations sufficient to neutralize 103 units/ml of either HuIFN-c~ types or HuIFN-fl as described in Table 3 . As illustrated in Table 3 , HuIFN antisera markedly decreased the antiviral activity of microinjected poly(rI), poly(rC). However, in none of the five different experiments we have performed was there complete neutralization of this activity. The reason for this will be discussed later.
Although the IFN-inducing capacity of poly(rI), poly(rC) has generally been considered to be responsible for its antiviral activity, it has also been proposed that a direct effect on cell metabolism could contribute to inhibition of virus multiplication (Burke, 1977; Marcus, 1983) . This would explain the incomplete neutralization by IFN antibodies we observed. However, our own experiments (Faure et al., 1984; P. G. Milhaud, M. Silhol, T. Salehzada & B. Lebleu, unpublished results) at least do not favour an involvement of cell cytotoxicity of microinjected poly(rI).poly(rC) apart from the low (< 10~) cell mortality inherent in the microinjection procedure itself.
Antiviral activity of microinjected poly(rl).poly(rC) can be transferred from cell to cell
If IFN synthesis and secretion induced by microinjected poly(rI), poly(rC) contributed to its antiviral activity as suggested by the experiments described above, this protective effect should be transferable to uninjected cells. As illustrated in Table 4 , VSV production was still inhibited when as few as 15 ~ of the cell population had been injected with poly(rI), poly(rC), although the figure varied from experiment to experiment. The injected cells were not in direct contact so that the interspecific transfer of IFN-induced antiviral activity reported by Blalock et al. (1980) could not have accounted for our observations.
To exploit the species specificity of IFN as an additional criterion for its involvement in the' development of an antiviral state in poly(rI).poly(rC)-microinjected HeLa cells, the conditioning experiments described in Table 5 were conducted. In the first experiment (expt. 1), HeLa cells grown on coverslip fragments were injected with poly(rI), poly(rC) or left untreated and incubated for 18 h in culture medium as usual. Aliquots of the conditioned medium were dispensed in several microtitre plate wells wherein glass-attached homologous (HeLa) or heterologous (murine L929, CHO) cells were incubated for an additional 18 h before challenge 1871 * HeLa cells were grown on 2 mm 2 glass pieces as indicated in Methods. A portion of the cell population was microinjected as indicated with poly(rI), poly(rC) and challenged with VSV as described in Table 1 . Virus yields were determined by plaque assay on L929 cells. t In expt. 1,200 cells attached to 2 mm 2 glass pieces were microinjected with 0.5 nl each of a 1 Ixg/ml aqueous solution of poly(rI).poly(rC) and incubated for 18 h in 60 ~tl of culture medium in a microtitre well. The conditioned medium was then transferred to another well with or without 500 units HulFN-~fl antibodies (IFN-~fl Ab), as indicated. Around 200 uninjected cells of the indicated species (HeLa, L929 or CHO) attached to small glass pieces were incubated in this conditioned medium and challenged 18 h later with VSV. Controls were run in a similar way with medium conditioned by uninjected HeLa cells or uninjected HeLa cells treated with a mixture of , or with heat-treated (10 rain at 65 °C) culture medium from poly(rI)-poly(rC)-injected HeLa ceils. In expt. 2 around 400 cells on 2 mm z glass coverslips were left untreated, treated with 103 units of HulFN-ct2 and 103 units of HulFN-fl or microinjected with poly(rl), poly(rC) as described for expt. 1 except for the addition of 10 ~tg/ml RNase A in the culture medium at the time of microinjection. Coverslip-attached cells were then incubated for 18 h with 200 gl culture medium (with or without RNase A) in a microtitre well. Sixty I11 aliquots of the conditioned medium were dispatched in three wells with or without 500 units HulFN-~fl antibodies as indicated. Around 200 homologous (HeLa) or heterologous (L929) cells attached to small glass pieces were incubated in this conditioned medium and challenged with VSV 18 h later as described in Methods.
with VSV. An antiviral agent had clearly been released in the culture medium during the conditioning period which showed the same species specificity as IFN and was neutralized to a large extent by anti-IFN polyclonal antibodies. As had also been expected for IFN, a brief heat treatment (30 min at 65 °C) of the conditioned medium before transfer to uninjected cells abolished its antiviral potential. The second experiment (expt. 2) led to the same conclusions but differed from expt. 1 by the presence of RNase A to neutralize the IFN-inducing capacity of any poly(rI)-poly(rC) leaking from the microinjected cells.
DISCUSSION
These studies demonstrate the ability of poly(rI)-poly(rC) to reduce VSV multiplication when microinjected into the cytoplasm of different cell lines. The efficiency of virus protection of the cells injected with poly(rI), poly(rC) appears to be remarkable, especially for HeLa cells which are poorly sensitive to exogenous poly(rI), poly(rC). A rough calculation indicates that a few molecules of injected poly(rI).poly(rC) represent the threshold value for the development of antiviral activity in this system. This estimate has been calculated assuming an average volume of injection of 5 x 10 -l° ml and a mean mol. wt. for poly(rI).poly(rC) of 106 as given by the manufacturers. This is much less than the doses found to be efficient for exogenous dsRNA inducers (around l0 s molecules/cell; Gordon & Minks, 1981) and comes close to the threshold for IFN induction of one molecule of intracellular dsRNA per cell reported by Marcus (1983) . The observed antiviral response apparently results from IFN secretion, but a direct protective effect of poly(rI)-poly(rC) in the injected cell is not excluded. Indeed, a fairly good level of antiviral protection is attained when cells are challenged with VSV 2 h after the introduction of poly(rI), poly(rC) or if the cells are microinjected in the presence of 5 ~tg/ml actinomycin D (data not shown). Since mRNA transcription is completely inhibited at this antibiotic concentration, the reduction of VSV yield observed in these conditions could not be attributed to the well established transcriptional activation of IFN genes (Collins, 1984) . Although no precise mechanism(s) could be ascertained for this effect, it would not be unexpected since dsRNAs have known biological effects in cells besides IFN induction. Indeed, dsRNAs could affect viral protein synthesis and RNA metabolism through the activation of a dsRNA-dependent protein kinase and of the 2-5A pathway, as well as through still unidentified alternative pathways (see Johnston & Torrence, 1984) . Although these dsRNA-dependent enzymes are largely inducible by exogenous IFN treatment, their basal level in many cell lines including HeLa cells could lead to an activation of the corresponding pathway in the presence of the appropriate dsRNA activator. Taken together, the observations presented here suggest, but by no means prove, a unitary mechanism for IFN induction by viruses and by synthetic polynucleotides. Some viruses such as VSV [_+] RNA defective interfering particles (Marcus & Sekellick, 1977) or bluetongue virus (Jameson et al., 1980) provide an efficient vector for intracellular inoculation of doublestranded RNA.
The mechanism(s) involved in the internalization of poly(rI).poly(rC) in this system is unknown. Studies by our group on the toxicity of poly(rI), poly(rC) for IFN-treated murine cells (Faure et al., 1984; P. G. Milhaud, M. Silhol, T. Salehzada & B. Lebleu, unpublished) strongly suggest the involvement of fluid-phase endocytosis.
